- US11993599utility2024Therapeutic Compounds0 cites
- US11987637utility2024Prevention of Disulfide Bond Reduction During Recombinant Production of Polypeptides0 cites
- US11987638utility2024Prevention of Disulfide Bond Reduction During Recombinant Production of Polypeptides0 cites
- US11976127utility2024Prevention of Disulfide Bond Reduction During Recombinant Production of Polypeptides0 cites
- US11969426utility2024Pharmaceutical Compositions Comprising Akt Protein Kinase Inhibitors0 cites
- US11963994utility2024Inhibitors of IAP0 cites
- US11967072utility2024Three-dimensional Object Segmentation of Medical Images Localized with Object Detection0 cites
- US11958906utility2024Pharmaceutical Compositions of Mosunetuzumab and Methods of Use0 cites
- US11944606utility2024Azaindoles as Inhibitors of HPK10 cites
- US11945837utility2024Ion Exchange Membrane Chromatography0 cites
- US11938189utility2024Compositions and Methods for Stabilizing Protein-containing Formulations0 cites
- US11939396utility2024Anti-tryptase Antibodies, Compositions Thereof, and Uses Thereof0 cites
- US11939559utility2024Method of Culturing Eukaryotic Cells0 cites
- US11925624utility2024Methods of Administering Anti-fibrotic Therapy0 cites
- US11926674utility2024Anti-jagged2 Antibodies and Methods of Use0 cites
- US11918561utility2024Treatment of Breast Cancer Using Combination Therapies Comprising GDC-9545 and a CDK4/6 Inhibitor0 cites
- US11919948utility2024Isoform-selective Anti-tgfβ Antibodies and Methods of Use0 cites
- US11912773utility2024Fc Variants and Methods for Their Production0 cites
- US11912823utility2024Methods of Preparing a Poloxamer for Use in Cell Culture Medium0 cites
- US11896810utility2024Injection Monitoring Device with Delivery Signature0 cites